A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...
Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback